Acutaas Chemicals Ltd · NSE:ACUTAAS
Acutaas Chemicals — Q3 FY26 Earnings Presentation
11 slides from Acutaas Chemicals's earnings presentation, Jan 28, 2026
Slide 1: Acutaas Chemicals Limited – Investor Presentation filing
A fi C U T a a S'M ACUTAAS CHEMICALS LIMITED (Formerly known as Ami Organics Limited) CIN No. : L24100GJ2007PLCO51093 You and us: chemistry’s apex January 28, 2026 To, To, The Listing Department, The Listing Department BSE LIMITED, National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers,
Slide 2: Earnings Presentation January 2026
EARNINGS PRESENTATION JANUARY 2026 www.acutaas.com www.acutaas.com
Slide 3: Management Commentary
Management Commentary (Mn.) Revenue for Q3 FY26 Mr. Naresh Patel Executive Chairman and Managing Director “We continue to reinforce our core pharmaceutical intermediates ₹3,932 YoY 43.0% business through the addition of CMO/CDMO opportunities alongside strengthening our business foundation by scalin
Slide 4: Q3 FY26 Financial Performance – Key Metrics
Q3 FY26 Financial Performance – Key Metrics Revenue from Operations (₹ Mn.) Q3 FY26 Earnings & Business Highlights YoY Growth 47.0% 16.5% 43.0% 3,932 Robust growth in Advanced Pharmaceutical 3,511 Intermediates business supported by strong 2,750 2,389 Ramp up in CDMO, with specialty chemicals busine
Slide 5: Q3 FY26 Financial Performance – P&L Statement
Q3 FY26 Financial Performance – P&L Statement Particulars (₹ Mn) Q3EY26 Q3FY25 YoY Q2FY26 QoQ 9MFY26 9MFY25 YoY Revenue from Operations 3,932 2,750 43.0% 3,062 28.4% 9,066 6,984 29.8% COGS 1,692 1,478 1,355 4,015 3,897 Gross Profit 2,240 1,272 76.1% 1,707 31.2% 5,051 3,087 63.6% Gross Margin 57.0% 4
Slide 6: Financial Performance over the years – Key Metrics
Financial Performance over the years – Key Metrics Revenue from Operations- Growth Trends (₹ Mn.) EBITDA and EBITDA Margins (₹ Mn. & %) FY20-25 CAGR: EBITDA (₹ Mn) EBITDA Margin (%) 29.8% 83.2% 33.3% 32.7% FY20 FY21 FY22 FY23 FY24 FY25 9MFY26 8,540 23.0% 23.5% 7,175 9,066 6,170 7,812 20.2% 19.9% 5,6
Slide 7: Financial Performance over the years - Profit and Loss
Financial Performance over the years - Profit and Loss Particulars (₹ Mn.) FY21 FY22 FY23 FY24 FY25 9MFY26 Revenue from Operations 3,406 5,201 6,167 7,175 10,069 9,066 Other Income 14 28 43 75 169 305 Total Income 3,420 5,229 6,210 7,250 10,238 9,371 Cost of materials consumed 1,749 2,823 3,459 4,40
Slide 8: Financial Performance over the years - Balance Sheet
Financial Performance over the years - Balance Sheet Equity and Liabilities (₹ Assets (₹ Mn.) FY21 FY22 FY23 FY24 FY25 H1 FY26 FY21 FY22 FY23 FY24 FY25 H1 FY26 Mn.) Property, plant and equipment 1,422 1,584 1,844 3,229 4,629 5,698 Shareholder's equity 1,669 5,223 5,939 6,828 13,201 14,391 Right of u
Slide 9: Shareholder Information
Shareholder Information Shareholding as on 31st December 2025 Share Information as on 31st December 2025 Promoters Others NSE Ticker ACUTAAS 29.0% 32.7% BSE Ticker 543349 Market Cap (₹ Cr.) 13,958 Shares Outstanding 8,18,71,122 3M ADTV (Shares) 3,50,109 3M ADTV (₹ Cr.) 59.2 MF FII 16.7% Other DII 15
Slide 10: Safe Harbor
Safe Harbor The Presentation is to provide the general background information about the Company’s activities as at the date of the Presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation that any
Slide 11: Contact Us
Contact Us For more information please contact: Acutaas Chemicals Limited Ekta Srivastava Company Secretary & Compliance Officer cs@acutaas.com Rahul Thakur Senior Manager – Investor Relations Rahul.thakur@acutaas.com www.acutaas.com www.acutaas.com